Tenax Therapeutics, Inc.

3.84 USD
-0.14 (-3.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tenax Therapeutics, Inc. stock is down -61.94% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 9 February’s closed higher than January. 100% of analysts rate it a buy.

About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company was founded in 1967 and is headquartered in Morrisville, North Carolina.